CLEC5A and COVID-19: This work clearly demonstrates that PLT-EVs from COVID-19 patients can enhance thromboinflammation via CLEC5A and TLR2, and further shows that PLT-EVs from virus-activated act as endogenous danger signals to cause systemic inflammation.